These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 6965974)

  • 21. Protection from T helper cell-mediated graft-versus-host disease by the presence of an MHC class I alloantigen is associated with perturbation of MHC class II-restricted responses by class I-derived peptides.
    Leibnitz RR; Lipsky PE; Thiele DL
    J Immunol; 1995 Aug; 155(4):1784-95. PubMed ID: 7636234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Definition of a new T lymphocyte cell surface antigen, Ly 11.2.
    Meruelo D; Paolino A; Flieger N; Offer M
    J Immunol; 1980 Dec; 125(6):2713-8. PubMed ID: 6968793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dichotomy in the tissue origin of schistosome acquired class I and class II major histocompatibility complex antigens.
    Sher A; Sacks DL; Simpson AJ; Singer A
    J Exp Med; 1984 Mar; 159(3):952-7. PubMed ID: 6366108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic control of cytolytic T lymphocyte responses. III. The role of K and I region alleles on the specificity of the cytolytic T lymphocyte response to trinitrophenyl-modified syngeneic cells.
    Burakoff SJ; Riccio J; Billings P; Benacerraf B; Dorf ME
    J Immunol; 1980 Oct; 125(4):1432-5. PubMed ID: 6967901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. II. Cellular requirements for T cell transformation mediated by a soluble Mycoplasma mitogen.
    Cole BC; Sullivan GJ; Daynes RA; Sayed IA; Ward JR
    J Immunol; 1982 May; 128(5):2013-8. PubMed ID: 6977580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of interleukin-1 and interleukin-6 in murine primary schistosomiasis.
    El Ridi R; Wagih A; Salem R; Mahana N; El Demellawy M; Tallima H
    Int Immunopharmacol; 2006 Jul; 6(7):1100-8. PubMed ID: 16714213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accessory molecules involved in antigen-mediated cytolysis and lymphokine production by cytotoxic T lymphocyte subsets. I. Identification of functions for the T cell surface molecules Ly-6C and Thy-1.
    Johnson R; Lancki DW; Fitch FW
    J Immunol; 1993 Sep; 151(6):2986-99. PubMed ID: 8104217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies of the antibody-dependent killing of schistosomula of Schistosoma mansoni employing haptenic target antigens. II. In vitro killing of TNP-schistosomula by human eosinophils and neutrophils.
    Moser G; Sher A
    J Immunol; 1981 Mar; 126(3):1025-9. PubMed ID: 7462624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The regulation of resistance to Schistosoma mansoni by a soluble alpha/beta TCR analog, produced by a cloned T cell hybridoma.
    Perrin PJ; Phillips SM
    Cell Immunol; 1993 Jun; 149(1):155-69. PubMed ID: 8513510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of H-2-restricted cytotoxic T cells by ultraviolet light-treated trinitrophenyl-modified syngeneic cells: increased requirement for adherent cells.
    Hurme M; Bång BE; Sihvola M
    J Immunol; 1980 Dec; 125(6):2484-8. PubMed ID: 6968785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of T cell receptors specific for recognition of class IB antigens.
    Lowen LC; Aldrich CJ; Forman J
    J Immunol; 1993 Dec; 151(11):6155-65. PubMed ID: 8245458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of major histocompatibility complex class I on neural stem cells does not permit natural killer cell killing and prevents recognition by alloreactive cytotoxic T lymphocytes in vitro.
    Mammolenti M; Gajavelli S; Tsoulfas P; Levy R
    Stem Cells; 2004; 22(6):1101-10. PubMed ID: 15536199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of T cells with differential responses to alloantigens in CD45 exon 6-deficient mice.
    Kong YY; Kishihara K; Yoshida H; Mak TW; Nomoto K
    J Immunol; 1995 Jun; 154(11):5725-35. PubMed ID: 7751624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes.
    Zaccone P; Fehérvári Z; Jones FM; Sidobre S; Kronenberg M; Dunne DW; Cooke A
    Eur J Immunol; 2003 May; 33(5):1439-49. PubMed ID: 12731071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Murine alloantigen acquisition by schistosomula of Schistosoma mansoni: further evidence for the presence of K, D, and I region gene products on the tegumental surface.
    Gitter BD; Damian RT
    Parasite Immunol; 1982 Nov; 4(6):383-93. PubMed ID: 6185906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carcinogen-treated skin allografts rejected by T lymphocytes specific for class I but not class II MHC antigens.
    Halliday GM; Odling KA; Muller HK
    Cell Immunol; 1993 Oct; 151(2):291-9. PubMed ID: 8402936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni.
    Wynn TA; Eltoum I; Cheever AW; Lewis FA; Gause WC; Sher A
    J Immunol; 1993 Aug; 151(3):1430-40. PubMed ID: 8335939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the surface antigenicity and susceptibility to antibody-dependent killing of developing schistosomula using sera from chronically infected mice and mice vaccinated with irradiated cercariae.
    Bickle QD; Ford MJ
    J Immunol; 1982 May; 128(5):2101-6. PubMed ID: 7061855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resistance induced by drug abbreviated Schistosoma mansoni infections: treatment with the drug Ro11-3128 leads to enhanced antigen presentation.
    Smith DA; Bickle QD; Kaye PM
    Immunology; 1994 Jul; 82(3):419-26. PubMed ID: 7959877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Destruction of the multicellular parasite Schistosoma mansoni by T lymphocytes.
    Ellner JJ; Olds GR; Lee CW; Kleinhenz ME; Edmonds KL
    J Clin Invest; 1982 Aug; 70(2):369-78. PubMed ID: 6980229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.